Conference abstract · 25 Sep 2017
Conference abstractPublished 16 Feb 2019
The potential role of propolis on the therapeutic effectiveness of L-dopa during development of parkinsonism in rats
Al-Azhar University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Parkinson's disease (PD) is a geriatric neurodegenerative disorder where neuroinflammation and oxidative stress play a prominent role in the mechanisms underlying dopaminergic neurons degeneration. The immediate dopamine precursor L-dopa was the first efficient drug for PD treatment and remains the mainstay one, however long-term use is associated with motor fluctuations and dyskinesias. Propolis is one of the most important resinous natural product with wide range of biological activities as antiinflammatory and antioxidant, it has been demonstrated for prevention of geriatric neurodegenerations. Objective: To evaluate the efficacy of Propolis either alone or with L-dopa against rotenone-induced PD in rats and to investigate the possibility of using Propolis as an adjunct therapy for reducing L-dopa dosage without compromising its therapeutic outcome. Methods: Six groups of rats were used for 19 days; one normal group and five Rotenone (2.5 mg/kg SC) groups. One of the RT groups served as control PD model while the others treated with each of the following: L-dopa (10 or 25 mg/kg PO), Propolis (300 mg/kg PO) or both Propolis and L-dopa (10 mg/kg PO). Catalepsy, open-field and Y-maze tests were used for assessment of motor and cognitive performances. Striatal monoamines, acetylcholinesterase (AChE) as well as mitochondrial complex-1 were measured. In addition, oxidative stress and neuroinflammatory markers as well as caspase-3 expression were also evaluated besides histopathological examinations of different brain regions. Results: Treatment with Propolis and/or L-dopa ameliorated cognition and locomotor activity impairments induced by RT. Moreover, depletions in monoamines, mitochondrial complex-1 and elevations in AchE, caspase-3 expression oxidative as well as neuroinflammatory markers were also decreased. Histopathological examinations confirmed the pronounced effects obtained by combination of Propolis with low dose L-dopa than the higher used dose alone. Conclusion: Propolis is efficient in protection from PD development and represents a suitable adjuvant therapy that can be translated to marked reduction of the long-term treatment side effects by the mainstay therapy L-dopa. Consequently, Propolis could be recommended as a disease-modifying therapy of PD as well as a promising adjuvant therapy with L-dopa especially when given early in the treatment course.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Dec 2016
Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's disease
Conference abstract · 30 Oct 2017
Impact of vinpocetine on the therapeutic effectiveness of L-DOPA using rat model of ParkinsonâÂ?²s Disease
Conference abstract · 2016
Environmental enrichment improves the anti-cataleptic effect of L-DOPA in Parkinsonian rats: A possible role of endogenous ligands of Trkb receptors
Conference abstract · 3 Sep 2021
The Electroactive Signal for the Tau Peptide- Part 2: Neuromolecular Imaging (NMI): A LIVE Nanotechnology for Alzheimer, Parkinson and Epilepsy Disease: The BRODERICK PROBE� Biosensor Images the Effects of the Pharmaceutical, L-DOPA, in Long-Term Neurodegeneration in Parkinson Subjects
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Azza A Ali”
